P
UN

Pitcairn’s Unilever NV New York Registry Shares UN Stock Holding History

Pitcairn’s Portfolio UN Stock Details UN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,172
Closed -$977K – 592
2020
Q3 		$977K Buy
16,172
+760
+5% +$44K 0.08% 151
2020
Q2 		$821K Sell
15,412
-345
-2% -$17.5K 0.08% 157
2020
Q1 		$769K Buy
15,757
+7,439
+89% +$407K 0.09% 135
2019
Q4 		$478K Buy
+8,318
New +$491K 0.04% 266

Other funds holding UN

FTB
First Trust Bank Nassau, Bahamas $50.9M AUM 33.51% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CVM
Cheviot Value Management Beverly Hills, California $996M AUM 25.52% 1-Year Est. Return
BA
Birinyi Associates Westport, Connecticut $367M AUM 25.62% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
EFSCE
Enterprise Financial Services Corp (EFSC) Clayton, Missouri $197M AUM 19.57% 1-Year Est. Return
HCM
Horrell Capital Management Little Rock, Arkansas $219M AUM 21.7% 1-Year Est. Return

Pitcairn's UN Position: Q4 2020 in Review

Pitcairn sold out of Unilever NV New York Registry Shares (UN) in Q4 2020, closing a stake of 16,172 shares — an estimated $977K sold.

Pitcairn first reported a position in UN in Q4 2019 and held it in 4 quarters. The position peaked at $977K in Q3 2020. 7 funds tracked by Wall St. Rank hold UN as of Q4 2020.

  • Pitcairn reported no remaining Unilever NV New York Registry Shares position as of Q4 2020 after selling out during the quarter.
  • Pitcairn sold 16,172 Unilever NV New York Registry Shares shares in Q4 2020, an estimated $977K.
  • Pitcairn first reported a position in Unilever NV New York Registry Shares in Q4 2019 and held it in 4 quarters.
  • Pitcairn's Unilever NV New York Registry Shares position peaked at $977K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Unilever NV New York Registry Shares as of Q4 2020.

Based on Pitcairn's 13F filing for Q4 2020, filed 5 Feb 2021.